Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Flucitosina")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 252

  • Page / 11
Export

Selection :

  • and

Validation of 24-Hour Flucytosine MIC Determination by Comparison with 48-Hour Determination by the Clinical and Laboratory Standards Institute M27-A3 Broth Microdilution Reference MethodLOCKHART, Shawn R; BOLDEN, Carol B; IQBAL, Naureen et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 12, pp 4322-4325, issn 0095-1137, 4 p.Article

Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeastPALUSZYNSKI, John P; KLASSEN, Roland; MEINHARDT, Friedhelm et al.Microbiology (Reading). 2008, Vol 154, pp 3154-3164, issn 1350-0872, 11 p., 10Article

Stability of flucytosine 50 mg/ml in extemporaneous oral liquid formulationsVANDENBUSSCHE, Heather L; JOHNSON, Cary E; JIN YUN et al.American journal of health-system pharmacy. 2002, Vol 59, Num 19, pp 1853-1855, issn 1079-2082Article

Life-threatening 5-fluorouracil-like cardiac toxicity after treatment with 5-fluorocytosineISETTA, C; GARAFFO, R; BASTIAN, G et al.Clinical pharmacology and therapeutics. 2000, Vol 67, Num 3, pp 323-325, issn 0009-9236Article

Population pharmacokinetics of flucytosine : Comparison and validation of three models using STS, NPEM, and NONMEMVERMES, Andras; MATHOT, Ron A. A; VAN DER SIJS, I. Heleen et al.Therapeutic drug monitoring. 2000, Vol 22, Num 6, pp 676-687, issn 0163-4356Article

Flucytosine monotherapy for cryptococcosisHOSPENTHAL, D. R; BENNETT, J. E.Clinical infectious diseases. 1998, Vol 27, Num 2, pp 260-264, issn 1058-4838Article

Expression profiling of the response of Saccharomyces cerevisiae to 5-fluorocytosine using a DNA microarrayLIANG ZHANG; YAN ZHANG; YIMING ZHOU et al.International journal of antimicrobial agents. 2002, Vol 20, Num 6, pp 444-450, issn 0924-8579, 7 p.Article

Flucytosine resistance is restricted to a single genetic clade of Candida albicansPUJOL, Claude; PFALLER, Michael A; SOLL, David R et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 262-266, issn 0066-4804, 5 p.Article

Flucytosine Antagonism of Azole Activity versus Candida glabrata: Role of Transcription Factor Pdr1 and Multidrug Transporter Cdr1STEIER, Zoë; VERMITSKY, John-Paul; TONER, Geoffrey et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5543-5547, issn 0066-4804, 5 p.Article

Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal MeningitisLOYSE, Angela; WILSON, Douglas; WOOD, Robin et al.Clinical infectious diseases. 2012, Vol 54, Num 1, pp 121-128, issn 1058-4838, 8 p.Article

In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in SerbiaTRPKOVIC, A; PEKMEZOVIC, M; BARAC, A et al.Journal de mycologie médicale. 2012, Vol 22, Num 3, pp 243-248, issn 1156-5233, 6 p.Article

Loss of Heterozygosity of FCY2 Leading to the Development of Flucytosine Resistance in Candida tropicalisCHEN, Yen-Ning; LO, Hsiu-Jung; WU, Chia-Chen et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 6, pp 2506-2514, issn 0066-4804, 9 p.Article

A Novel Flucytosine-Resistant Yeast Species, Candida pseudoaaseri, Causes Disease in a Cancer PatientPFÜLLER, Roland; GRÄSER, Yvonne; ERHARD, Marcel et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 12, pp 4195-4202, issn 0095-1137, 8 p.Article

Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant RecipientCHAPELAND-LECLERC, Florence; HENNEQUIN, Christophe; PAPON, Nicolas et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 3, pp 1360-1362, issn 0066-4804, 3 p.Article

Combination Flucytosine and High-Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in MalawiNUSSBAUM, Jesse C; JACKSON, Arthur; VAN DER HORST, Charles M et al.Clinical infectious diseases. 2010, Vol 50, Num 3, pp 338-344, issn 1058-4838, 7 p.Article

A Ser29Leu Substitution in the Cytosine Deaminase Fcalp Is Responsible for Clade-Specific Flucytosine Resistance in Candida dubliniensisMCMANUS, Brenda A; MORAN, Gary P; HIGGINS, Judy A et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 11, pp 4678-4685, issn 0066-4804, 8 p.Article

Bacterial Cytosine Deaminase Mutants Created by Molecular Engineering Show Improved 5-Fluorocytosine-Mediated Cell Killing In vitro and In vivoFUCHITA, Michi; ARDIANI, Andressa; LEI ZHAO et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 11, pp 4791-4799, issn 0008-5472, 9 p.Article

A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapyBOUCHER, Paul D; IM, Michael M; FREYTAG, Svend O et al.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 3230-3237, issn 0008-5472, 8 p.Article

Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosineO'BRIEN, Tracey A; TUONG, Dong T; BASSO, Lisa M et al.Human gene therapy. 2006, Vol 17, Num 5, pp 518-530, issn 1043-0342, 13 p.Article

Enhanced retention of polar analytes utilizing novel 1.7 μm UPLC™ particles for hydrophilic interaction chromatographyGRUMBACH, Eric S; WHEAT, Thomas E; MAZZEO, Jeffrey R et al.LC GC North America. 2006, Vol FEV, pp 70-71, issn 1527-5949, 2 p., SUPArticle

In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida speciesKARLOWSKY, James A; HOBAN, Daryl J; ZHANEL, George G et al.International journal of antimicrobial agents. 2006, Vol 27, Num 2, pp 174-177, issn 0924-8579, 4 p.Article

Immunotherapy of murine prostate cancer using whole tumour cells killed exvivo by cytosine deaminase/5-fluorocytosine suicide-gene therapyPANDHA, Hardev S; COOK, Dorthe; GREENHALGH, Rebecca et al.BJU international (Papier). 2005, Vol 95, Num 9, pp 1336-1343, issn 1464-4096, 8 p.Article

Protein transduction with bacterial cytosine deaminase fused to the TLM intercellular transport motif induces profound chemosensitivity to 5-fluorocytosine in human hepatoma cellsHILLEMANN, Annett; BRANDENBURG, Boerries; SCHMIDT, Ulrike et al.Journal of hepatology. 2005, Vol 43, Num 3, pp 442-450, issn 0168-8278, 9 p.Article

Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasisHOPE, William W; WARN, Peter A; SHARP, Andrew et al.The Journal of infectious diseases. 2005, Vol 192, Num 4, pp 673-680, issn 0022-1899, 8 p.Article

The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy : in vitro susceptibility of 375 Candida albicans isolates and biofilm productionTORTORANO, Anna Maria; PRIGITANO, Anna; BIRAGHI, Emanuela et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 4, pp 777-779, issn 0305-7453, 3 p.Article

  • Page / 11